Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine

New discovery of high-affinity SARS-CoV-2 spike S2 protein binding peptide selected by PhIP-Seq

Persisting lung pathogenesis and minimum residual virus in hamster after acute COVID-19

The prevalence of antibodies to SARS-CoV-2 among blood donors in China

Virus-Free and Live-Cell Visualizing SARS-CoV-2 Cell Entry for Studies of Neutralizing Antibodies and Compound Inhibitors

Rapid Neutralization Testing System for Zika Virus Based on an Enzyme-Linked Immunospot Assay

Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16

Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells

HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation

Development of an efficient neutralization assay for Coxsackievirus A10

Expression of Human Cytomegalovirus IE1 Leads to Accumulation of Mono-SUMOylated PML That Is Protected from Degradation by Herpes Simplex Virus 1 ICP0

Optimized HepaRG is a suitable cell source to generate the human liver chimeric mouse model for the chronic hepatitis B virus infection

A Chimeric Humanized Mouse Model by Engrafting the Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cell for the Chronic Hepatitis B Virus Infection

Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody

A neonatal mouse model of coxsackievirus A10 infection for anti-viral evaluation